Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 207

1.

Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.

Gevi F, Zolla L, Gabriele S, Persico AM.

Mol Autism. 2016 Nov 24;7:47. eCollection 2016.

2.

The urinary 1 H-NMR metabolomics profile of an italian autistic children population and their unaffected siblings.

Lussu M, Noto A, Masili A, Rinaldi AC, Dessì A, De Angelis M, De Giacomo A, Fanos V, Atzori L, Francavilla R.

Autism Res. 2017 Jun;10(6):1058-1066. doi: 10.1002/aur.1748. Epub 2017 Mar 11.

PMID:
28296209
3.

Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.

Muñóz-Hoyos A, Molina-Carballo A, Rodríguez-Cabezas T, Uberos-Fernández J, Ruiz-Cosano C, Acuña-Castroviejo D.

Clin Endocrinol (Oxf). 1997 Dec;47(6):667-77.

PMID:
9497873
4.

Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Khaled EM, Meguid NA, Bjørklund G, Gouda A, Bahary MH, Hashish A, Sallam NM, Chirumbolo S, El-Bana MA.

Metab Brain Dis. 2016 Dec;31(6):1419-1426. Epub 2016 Jul 13.

PMID:
27406246
5.

Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.

Diémé B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P.

J Proteome Res. 2015 Dec 4;14(12):5273-82. doi: 10.1021/acs.jproteome.5b00699. Epub 2015 Nov 23.

PMID:
26538324
6.

Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.

West PR, Amaral DG, Bais P, Smith AM, Egnash LA, Ross ME, Palmer JA, Fontaine BR, Conard KR, Corbett BA, Cezar GG, Donley EL, Burrier RE.

PLoS One. 2014 Nov 7;9(11):e112445. doi: 10.1371/journal.pone.0112445. eCollection 2014.

7.

Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.

Gomez-Gomez A, Marcos J, Aguilera P, To-Figueras J, Pozo OJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Aug 15;1060:347-354. doi: 10.1016/j.jchromb.2017.06.030. Epub 2017 Jun 19.

PMID:
28666226
8.

Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.

Mussap M, Noto A, Fanos V.

Expert Rev Mol Diagn. 2016 Aug;16(8):869-81. doi: 10.1080/14737159.2016.1202765. Epub 2016 Jun 30. Review.

PMID:
27310602
9.

The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings.

Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, Casanova A, Fenu G, De Giacomo A, De Angelis M, Moretti C, Papoff P, Ditonno R, Francavilla R.

J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:46-52. doi: 10.3109/14767058.2014.954784.

PMID:
25284177
10.

Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.

Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X.

Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3.

PMID:
26150135
11.

[Studies on tryptophan metabolism in untreated phenylketonuric patients].

Kochen W, Byrd DJ, Bühner R, Bühlen E.

Z Klin Chem Klin Biochem. 1975 Jan;13(1):1-12. German.

PMID:
123676
12.

Metabolic perturbance in autism spectrum disorders: a metabolomics study.

Ming X, Stein TP, Barnes V, Rhodes N, Guo L.

J Proteome Res. 2012 Dec 7;11(12):5856-62. doi: 10.1021/pr300910n. Epub 2012 Nov 9.

PMID:
23106572
13.

Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.

14.

Alteration of mice L-tryptophan metabolism by the organophosphorous acid triester diazinon.

Seifert J, Pewnim T.

Biochem Pharmacol. 1992 Dec 1;44(11):2243-50.

PMID:
1282004
15.
16.

Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case-control study.

Aarsland TI, Landaas ET, Hegvik TA, Ulvik A, Halmøy A, Ueland PM, Haavik J.

Behav Brain Funct. 2015 Nov 5;11(1):36. doi: 10.1186/s12993-015-0080-x.

17.

Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?

Wilson J, Wright B, Jost S, Smith R, Pearce H, Richardson S.

Pediatr Res. 2017 Apr;81(4):672-679. doi: 10.1038/pr.2016.256. Epub 2016 Nov 23.

PMID:
27879968
19.

Altered kynurenine pathway metabolism in autism: Implication for immune-induced glutamatergic activity.

Lim CK, Essa MM, de Paula Martins R, Lovejoy DB, Bilgin AA, Waly MI, Al-Farsi YM, Al-Sharbati M, Al-Shaffae MA, Guillemin GJ.

Autism Res. 2016 Jun;9(6):621-31. doi: 10.1002/aur.1565. Epub 2015 Oct 24.

PMID:
26497015
20.

Effect of nicotinamide administration on the tryptophan-nicotinamide pathway in humans.

Fukuwatari T, Shibata K.

Int J Vitam Nutr Res. 2007 Jul;77(4):255-62.

PMID:
18271280

Supplemental Content

Support Center